Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity.

[1]  D. Gray,et al.  CD40 ligand-transduced co-stimulation of T cells in the development of helper function , 1995, Nature.

[2]  R. Flavell,et al.  Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand , 1995, Nature.

[3]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[4]  J. Gribben,et al.  B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. , 1995, Immunity.

[5]  C. Maliszewski,et al.  Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.

[6]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[7]  D. Lawrence,et al.  Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1 , 1995, European journal of immunology.

[8]  F. Alt,et al.  CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Suttles,et al.  Role of the CD40‐CD40 ligand interaction in CD4+ T cell contact‐dependent activation of monocyte interleukin‐1 synthesis , 1994, European journal of immunology.

[10]  R J Armitage,et al.  Humoral immune responses in CD40 ligand-deficient mice , 1994, The Journal of experimental medicine.

[11]  J. Banchereau,et al.  B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells , 1994, The Journal of experimental medicine.

[12]  A. Aruffo,et al.  Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. , 1994, The Journal of clinical investigation.

[13]  R. Flavell,et al.  Mice deficient for the CD40 ligand. , 1994, Immunity.

[14]  P. Linsley,et al.  Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. , 1994, Journal of immunology.

[15]  N. Yoshida,et al.  The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. , 1994, Immunity.

[16]  G. Trinchieri,et al.  Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones , 1994, The Journal of experimental medicine.

[17]  R. Locksley,et al.  CD4+ effector cells default to the Th2 pathway in interferon gamma- deficient mice infected with Leishmania major , 1994, The Journal of experimental medicine.

[18]  L. Lanier,et al.  B70 antigen is a second ligand for CTLA-4 and CD28 , 1993, Nature.

[19]  A. Sher,et al.  Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Aruffo,et al.  Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. , 1993, Science.

[21]  M. Gately,et al.  IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. , 1993, Journal of immunology.

[22]  W. Fanslow,et al.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40 , 1993, The Journal of experimental medicine.

[23]  G. Starling,et al.  B7/BB-1 is a leucocyte differentiation antigen on human dendritic cells induced by activation. , 1993, Immunology.

[24]  D. Wirth,et al.  Transfected Leishmania expressing biologically active IFN-gamma. , 1993, Journal of immunology.

[25]  R. Schaub,et al.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response , 1993, The Journal of experimental medicine.

[26]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[27]  C. Hsieh,et al.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.

[28]  G. Trinchieri,et al.  Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.

[29]  J. Belmont,et al.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome , 1993, Science.

[30]  L. Notarangelo,et al.  Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM , 1993, Nature.

[31]  A. Fischer,et al.  CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM , 1993, Nature.

[32]  J. Bajorath,et al.  The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome , 1993, Cell.

[33]  R. Coffman,et al.  Reconstitution of C.B‐17 scid mice with BALB/c T cells initiates a T helper type‐1 response and renders them capable of healing Leishmania major infection , 1993, European journal of immunology.

[34]  P. Casellas,et al.  Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. , 1992, The Journal of biological chemistry.

[35]  G. Freeman,et al.  Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: a potential mechanism for amplification of T cell activation through the CD28 pathway. , 1991, Cellular immunology.

[36]  R. Locksley,et al.  Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines. , 1991, Journal of immunology.

[37]  R. Locksley,et al.  Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. Abbas,et al.  Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution , 1990, Infection and immunity.

[39]  S. Moncada,et al.  Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.

[40]  R. Locksley,et al.  Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism , 1990, The Journal of experimental medicine.

[41]  M. Belosevic,et al.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major. , 1989, Journal of immunology.

[42]  G. Freeman,et al.  Isolated human follicular dendritic cells display a unique antigenic phenotype , 1989, The Journal of experimental medicine.

[43]  R. Locksley,et al.  Powered by the California Digital Library University of California RECIPROCAL EXPRESSION OF INTERFERON y OR INTERLEUKIN 4 DURING THE RESOLUTION OR PROGRESSION OF MURINE LEISHMANIASIS Evidence for Expansion of Distinct Helper T Cell Subsets , 2003 .

[44]  J. McKenzie,et al.  Isolation and characterization of human tonsil dendritic cells , 1988, The Journal of experimental medicine.

[45]  T. Boon,et al.  A limiting dilution assay for quantifying Leishmania major in tissues of infected mice , 1985, Parasite immunology.

[46]  C. Taswell,et al.  Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. , 1981, Journal of immunology.

[47]  R. Locksley,et al.  The regulation of immunity to Leishmania major. , 1995, Annual review of immunology.

[48]  J. Banchereau,et al.  The CD40 antigen and its ligand. , 1994, Annual review of immunology.

[49]  F. Liew,et al.  Immunology of leishmaniasis. , 1993, Advances in parasitology.

[50]  L. Notarangelo,et al.  Immunodeficiency with hyper-IgM (HIM). , 1992, Immunodeficiency reviews.

[51]  J. Louis,et al.  T-cell responses and immunity to experimental infection with leishmania major. , 1989, Annual review of immunology.